Pharmaboard interview regarding Regenerage:

https://pharmaboardroom.com/interviews/interview-dr-joel-osorio-co-founder-ceo-regenerage/

Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare:

http://www.prweb.com/releases/2016/07/prweb13559349.htm

Normalization of Vital Functions of Pathological Cells and Tissues By Key Mechanisms of Cell Adaptation and Reprogramming:

https://docs.wixstatic.com/ugd/1453f8_4f93562cfd51497f8563afebf72b4f77.pdf

Therapeutic Effects of Bioquantine™ in Volunteer Patients Diagnosed With T2D, CKD, SCI, Hypothyroidism, Atypical Pyoderma Gangrenous, and Breast Cancer:

 https://docs.wixstatic.com/ugd/1453f8_4fea01f82bb249dfb110c60dd3d9f427.pdf

Potential Threapeutic Applications of Extract Made from Electroporated Xenopus Laevis frog Oocytes in Murine Models of Melanoma, Traumatic Brain Injury and Experimental Skin Wrinkling:

https://docs.wixstatic.com/ugd/1453f8_c40182a4fb144cbd91efdf26ed45f5bb.pdf

Co‐Electroporation with Xenopus Laevis Oocytes Reprograms Normal and Cancerous Human Cells to Resemble Reprogramming Normal and Cancerous Human Cells to Resemble induced Human Pluripotent Stem Cells:

https://docs.wixstatic.com/ugd/1453f8_5b53d0a4742e4e4c9616e55222a5bc45.pdf